InVivo Therapeutics added Philadelphia-based University of Pennsylvania as a clinical site for the INSPIRE study.
Here are four points:
1. Penn Medicine is the 20th clinical site in the INSPIRE study.
2. James Schuster, MD, PhD, will serve as the site's principal investigator.
3. Dr. Schuster is an associate professor of neurosurgery and the associate director of the Neurocritical Care-Trauma.
4. The INSPIRE study tests the Neuro-Spinal Scaffold's efficacy and safety for complete thoracic AIS A spinal cord injury.